You are here

PD-L1

Study: PD-L1 may have Application in Obesity Treatment

BioSpace

Thu, 03/10/22 - 11:04 am

IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines

Fierce Biotech

Thu, 01/14/21 - 11:02 am

cancer vaccines

clinical trials

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug

Endpoints

Thu, 01/17/19 - 12:01 am

immuno-oncology

Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer

Fierce Pharma

Wed, 10/18/17 - 10:29 am

Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet

BioPharma Dive

Fri, 08/5/16 - 11:37 am

Bristol-Myers Squibb

non-small cell lung cancer

Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results

BioPharma Dive

Fri, 05/20/16 - 10:28 am

Merkel cell carcinoma

Roche, Kite Pharma sign CAR-T and PD-L1 combo deal

Fierce Biotech

Fri, 03/18/16 - 11:00 am

Roche's new PD-L1 bladder cancer drug could be on the market by September

Fierce Biotech

Tue, 03/15/16 - 10:35 pm

Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'

Fierce Biotech

Fri, 12/11/15 - 11:31 am

triple negative breast cancer

Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezo

Fierce Biotech

Mon, 07/13/15 - 09:49 am

Roche's new round of lung cancer data keeps spotlight on immunotherapies

Fierce Biotech

Mon, 09/30/13 - 05:00 pm

non-small cell lung cancer

Bristol Myers Squibb And The New Wave Of Cancer Drugs

Seeking Alpha

Mon, 05/20/13 - 05:26 pm

Bristol-Myers Squibb